Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
ACS Appl Mater Interfaces ; 16(8): 9690-9701, 2024 Feb 28.
Artigo em Inglês | MEDLINE | ID: mdl-38357740

RESUMO

The development of in vitro models recapitulating nanoparticle transport under physiological flow conditions is of great importance for predicting the efficacy of nanoparticle drug carriers. Liposomes are extensively used for drug delivery owing to their biocompatibility and biodegradability and the ability to carry both hydrophilic and hydrophobic compounds. Here, we used a library of liposomes with various dimensions and a microfluidic platform comprising a large array of uniformly sized breast cancer spheroids to explore size-dependent liposome internalization and retention in the spheroids under close-to-physiological interstitial conditions. Such a platform showed promising applications in the preclinical screening of small molecule drugs; however, the capability to deliver nanoparticles in the spheroid interior under close-to-physiological flow conditions was not explored. For the liposomes with diameters in the range of 45-200 nm, we show experimentally and by simulations that in comparison with liposome delivery solely by diffusion, flow significantly enhances liposome internalization in the microgels and mitigates the size-dependent spheroid penetration by the liposomes. The utility of the microfluidic platform was validated by evaluating the efficacy of clinically approved doxorubicin-loaded liposomes (Doxil), which exhibited superior retention in the spheroids under flow conditions, in comparison with free doxorubicin. This MF platform can serve as an in vitro model for screening the efficacy of drugs encapsulated in liposomes and find applications for screening other types of nanoparticle carriers for vaccine delivery, diagnostics, and skincare.


Assuntos
Doxorrubicina/análogos & derivados , Lipossomos , Neoplasias , Humanos , Lipossomos/química , Portadores de Fármacos/química , Microfluídica , Esferoides Celulares , Doxorrubicina/farmacologia , Polietilenoglicóis
2.
ACS Appl Mater Interfaces ; 15(3): 3791-3803, 2023 Jan 25.
Artigo em Inglês | MEDLINE | ID: mdl-36632842

RESUMO

Under healthy conditions, pro- and anti-phagocytic signals are balanced. Cluster of Differentiation 47 (CD47) is believed to act as an anti-phagocytic marker that is highly expressed on multiple types of human cancer cells including acute myeloid leukemia (AML) and lung and liver carcinomas, allowing them to escape phagocytosis by macrophages. Downregulating CD47 on cancer cells discloses calreticulin (CRT) to macrophages and recovers their phagocytic activity. Herein, we postulate that using a modified graphene oxide (GO) carrier to deliver small interfering RNA (siRNA) CD47 (CD47_siRNA) in AML, A549 lung, and HepG2 liver cancer cells in co-culture in vitro will silence CD47 and flag cancer cells for CRT-mediated phagocytosis. Results showed a high knockdown efficiency of CD47 and a significant increase in CRT levels simultaneously by using GO formulation as carriers in all used cancer cell lines. The presence of CRT on cancer cells was significantly higher than levels before knockdown of CD47 and was required to achieve phagocytosis in co-culture with human macrophages. Lipid nanoparticles (LNPs) and modified boron nitride nanotubes (BNPs) were used to carry CD47_siRNA, and the knockdown efficiency values of CD47 were compared in three cancer cells in co-culture, with an achieved knockdown efficiency of >95% using LNPs as carriers. Interestingly, the high efficiency of CD47 knockdown was obtained by using the LNPs and BNP carriers; however, an increase in CRT levels on cancer cells was not required for phagocytosis to happen in co-culture with human macrophages, indicating other pathways' involvement in the phagocytosis process. These findings highlight the roles of 2D (graphene oxide), 1D (boron nitride nanotube), and "0D" (lipid nanoparticle) carriers for the delivery of siRNA to eliminate cancer cells in co-culture, likely through different phagocytosis pathways in multiple types of human cancer cells. Moreover, these results provide an explanation of immune therapies that target CD47 and the potential use of these carriers in screening drugs for such therapies in vitro.


Assuntos
Antígeno CD47 , Leucemia Mieloide Aguda , Humanos , Antígeno CD47/metabolismo , Técnicas de Cocultura , Calreticulina/genética , Calreticulina/metabolismo , Fagocitose , RNA Interferente Pequeno
3.
Langmuir ; 38(3): 1011-1019, 2022 01 25.
Artigo em Inglês | MEDLINE | ID: mdl-35025525

RESUMO

The interaction between gold nanoparticles (AuNPs) with other components and phases has important consequences on their use in materials and devices as well as their fate in the environment or at biological interfaces. Previously we determined that long oil chain lengths and lower temperatures optimized the mixing of n-alkanes with alkanethiol-capped AuNPs which improved nanoparticle self-assembly into superlattices at aqueous interfaces. In this study, a variety of liquid phase hydrocarbon oils with structural and functional variations were surveyed for their mixing efficacy and propensity to enable reversible self-assembly of nanoparticle domains. Transmission electron microscopy (TEM) images and pressure vs area isotherms across this series reveal isotherm features that distinguish between the mixing and inclusion of the oil at the interface and that which enables reversible self-assembly. Structural and functional characteristics of the oil for promoting reversible self-assembly are identified which surpass the importance of chain length previously described. Temperatures below the ligand order-disorder transition were found to improve the reversibility of AuNP domains and are understood by application of a reparametrized x-DLVO model.


Assuntos
Ouro , Nanopartículas Metálicas , Microscopia Eletrônica de Transmissão , Óleos , Temperatura
4.
Annu Rev Phys Chem ; 68: 261-283, 2017 05 05.
Artigo em Inglês | MEDLINE | ID: mdl-28301758

RESUMO

Nanoparticles are widely studied for their potential medical uses in diagnostics and therapeutics. The interface between a nanoparticle and its target has been a focus of research, both to guide the nanoparticle and to prevent it from deactivating. Given nature's frequent use of phospholipid vesicles as carriers, much attention has been paid to phospholipids as a vehicle for drug delivery. The physical chemistry of bilayer formation and nanoparticle encapsulation is complex, touching on fundamental properties of hydrophobicity. Understanding the design rules for particle synthesis and encapsulation is an active area of research. The aim of this review is to provide a perspective on what preparative guideposts have been empirically discovered and how these are related to theoretical understanding. In addition, we aim to summarize how modern theory is beginning to help guide the design of functional particles that can effectively cross biological membranes.


Assuntos
Portadores de Fármacos/química , Bicamadas Lipídicas/química , Nanopartículas/química , Fosfolipídeos/química , Animais , Sistemas de Liberação de Medicamentos/métodos , Humanos , Interações Hidrofóbicas e Hidrofílicas , Lipossomos/química , Nanotecnologia/métodos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...